Targed Biopharmaceuticals Raises Eur 39 Million In Series A Financing To Bring Groundbreaking Thrombolytic Treatment To Patients
Amount Raised
€39 Million
Round Type
Series A
Description
TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today announces it has raised Series A financing of EUR 39 million to accelerate development of its lead compound, Microlyse. The financing was led with equal contribution by an international syndicate comprising Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors FIRST (Managed by BioGeneration Ventures), Curie Capital and Utrecht Health Seed Fund. TargED will focus development on two initial indications: acquired Thrombotic Thrombocytopenia Purpura (aTTP) and Acute Ischemic Stroke (AIS).
Quick answer
Targ Ed raised €39 Million in a Series A round, dated February 22, 2022.
- How much did Targ Ed raise?
- Targ Ed raised €39 Million in a Series A round on February 22, 2022.
- What does Targ Ed do?
- TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Source: Fundz verified event record.
Who to call at Targ Ed, and when
A new round usually means Targ Ed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Targ Ed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Targ Ed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Targ Ed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Targ Ed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTarg Ed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.